Evidence map›Paper›PMID 42371400›Full record

ArticlePain and therapy2026

French National Guidelines for the Appropriate Use of Opioids: Analgesia, Opioid Use Disorder, and Overdose Prevention-Part 2: Prevention and Management of Opioid Use Disorder and Overdose.

Célian Bertin, Julie Dupouy, Nicolas Authier, Nathalie Michenot, Sidonie Verdier, Mathieu Chappuy, Anne-Priscille Trouvin

Abstract read
In one paragraph

Article in Pain and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Célian BertinUMR Inserm 1107-Neuro-Dol, Université Clermont Auvergne, Clermont-Ferrand, France. cbertin@chu-clermontferrand.fr.ORCID http://orcid.org/0000-0002-2393-7061
Julie DupouyDépartement de Médecine Générale, Université de Toulouse, Toulouse, France.ORCID http://orcid.org/0000-0001-7801-286X
Nicolas AuthierUMR Inserm 1107-Neuro-Dol, Université Clermont Auvergne, Clermont-Ferrand, France.ORCID http://orcid.org/0000-0002-1236-0383
Nathalie MichenotEquipe de soins palliatifs, Centre Hospitalier de Versailles, Le Chesnay, France.
Sidonie VerdierEquipe Mobile de Soins Palliatifs, Département Interdisciplinaire de Soins de Support pour le Patient en Oncologie, Centre François Baclesse, Caen, France.ORCID http://orcid.org/0009-0006-9373-9606
Mathieu ChappuyService Universitaire d'Addictologie de Lyon, Groupement Hospitalier Centre, Hospices Civils de Lyon, Lyon, France.ORCID http://orcid.org/0000-0002-3176-6039
Anne-Priscille TrouvinUniversité Paris Cité, Paris, France.ORCID http://orcid.org/0000-0002-3524-7455

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Opioid use disorder (OUD) and overdoses represent critical challenges linked to the widespread availability of opioid medications. To address these risks, the French National Authority for Health convened a multidisciplinary working group to develop comprehensive guidelines on the prevention and management of OUD and overdoses. These recommendations expand on the second part of the guidelines, which specifically addressed the prevention and management of OUD and overdoses. Grounded in the highest level of international evidence and developed through a rigorous formal consensus process, the guidelines emphasize appropriate opioid prescribing as the cornerstone of prevention. They provide practical recommendations for identifying patients at risk, detecting problematic use early, and initiating opioid agonist treatment when indicated. The role of naloxone as an essential tool to prevent fatal overdoses is highlighted, along with strategies for coordinated and multidisciplinary care across diverse healthcare settings. By integrating prevention, treatment, and harm reduction measures, these guidelines seek to balance legitimate access to opioid analgesics with robust safeguards against opioid use disorder and overdose. Although developed within the French healthcare system, their strong evidence base and underlying clinical principles make them applicable to international practice. Together with the first part on pain management, they constitute one of the most comprehensive and up-to-date sets of recommendations on the safe and effective use of opioid medications.

Indexed as

Drug overdoseHarm reductionOpioid analgesicsOpioid dependenceOpioid-related disordersPain managementPractice guidelines

Identifiers

PMID42371400
PMCPMC13369064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.